William J. Link
Independent ChairmanDr. William J. Link, also known as Bill, Ph.D., is the Managing Partner at Flying L Partners. He served as Founder, Managing Partner and Principal at Flying L Partners. Director of ViaLase, Inc. He has been Chairman of the Board of Allegro Ophthalmics LLC since July 2021. He served as Director at Aurion Biotech, Inc. until October 2024. Dr. Link serves as an Director at RxSight, Inc. since November 2016. Dr. Link had been Director at Oyster Point Pharma, Inc. since July 2015 until March 17, 2022. Dr. Link serves as an Independent Director at Tarsus Pharmaceuticals, Inc. since January 2017. Dr. Link serves as Chairman of the Board at AcuFocus, Inc. since December 2019. Dr. Link also co-founded Versant Venture Management, LLC in 1999 and serves as its Managing Director. He is a Co-Founder and Managing Director of Versant Ventures since its inception in 1999. He specializes in early stage investing in medical devices. He has extensive knowledge of Medical Devices, Particularly in Ophthalmology and has contributed to Versant's recognized leadership in this specialty area. He was a General Partner of Brentwood Venture Capital since 1998, where he invested in a number of early stage companies. He founded Chiron Vision Corporation (acquired by Bausch & Lomb) in 1986 and also served as its Chairman and Chief Executive Officer from 1987 to 1997. He founded in 1978 and served as the President of American Medical Optics (acquired by Allergan). Before entering the health care industry, Dr. Link was an Assistant Professor in the Department of Surgery at the Indiana University School of Medicine from 1973 to 1976. He has been the Chairman of the Board at LENSAR, Inc. since November 8, 2017 and Aviana Molecular Technologies, LLC since June 2016. He served as the Chairman of AEON Biopharma, Inc. (formerly known as ALPHAEON Corporation) and Nexis Vision, Inc. He had been an Independent Director of Edwards Lifesciences Corp., since May 7, 2009 until May 4, 2021. He had been an Independent Director of Second Sight Medical Products, Inc. since August 2003 until May 31, 2020. He has been Independent Director of Allegro Ophthalmics LLC since November 21, 2016 and TrueVision Systems, Inc. since June 5, 2017. He serves as a Director of ForSight VISION4 and Oculeve, Inc. Dr. Link serves as a Director of ForSight VISION5, Inc. and ForSight VISION6, Inc. Dr. Link has also been a Member of the Board of Directors of DOSE Medical Corporation since October 2009. He serves as a Director of NeoVista, Inc. He served as a Director of ComeaGen Inc. (formerly known as CorneaGen Inc. (formerly known as SightLife Surgical, Inc.) and served as its Chairman until August 2020. He had been Chairman of the Board and Director at Glaukos Corporation since June 2001 until December 31, 2021. He serves as a Director of Acufocus, Inc. He serves as Chairman and Director of TearClear Corp. He served as a Director of ForSight Labs, LLC and Foresight Vision3, Inc. His affiliations and activities includes Founding Member of American College of Ophthalmic Surgery, Co-Chair of Blindness Annual Retinal Innovation Symposium, Co-Chair of Blindness Dining in the Dark, Co-Chair of Ophthalmology Innovation Summit - Conference, Trustee of Frederick N. Griffith Foundation at Tissue Banks International and Advisory Board Member of University of California, Irvine, Department of Biomedical Engineering. He served as the Chairman of Neurotech Pharmaceuticals, Inc. until August 2013 and served as its Director. He served as Chairman of Merge CAD Inc., NeoVista, Inc, Refractec, LLC and Foresight Vision3, Inc. He served as the Chairman of Intralase Corp. since July 2003 and Cameron Health, Inc., until May 2010. He served as a Director of Inogen, Inc., from 2003 to February 20, 2014 and Abbott Medical Optics Inc. (formerly, Advanced Medical Optics Inc.) from June 2002 to February 26, 2009. He served as a Director of FeRX Incorporated, Merge CAD Inc (formerly, Confirma Inc), Genyx, LensX Lasers, Inc., Intra Therapeutics, Refractec, LLC and OraMetrix, Inc. He served as a Director of Intralase Corporation since December 1998 and eyeonics, Inc. since October 1998. In February 2002, he was named as Engineer of the Year by the Orange County Engineering Council. Dr. Link is a pioneer and leader of the highly successful ophthalmology venture category. Dr. Link was also named to the 2011 Forbes Midas list. With operations experience in the healthcare industry, he has a proven record of building and operating large and successful Medical Product Companies. Dr. William was Director of Neurolens, Inc. until February 2025. Dr. Link holds Ph. D., M. S. and B. S. in Mechanical Engineering from Purdue University.
Positions
- Company NameLENSAR, Inc.Stock CodeLNSRPositionIndependent ChairmanColleagues
- NTNicholas T. CurtisPresident, CEO & Director
- WJWilliam J. LinkIndependent Chairman
- ABAlan B. ConnaughtonChief Operating Officer
- MAMichael A. RossiInterim CFO & Principal Financial Officer and Secretary
- KWKendra W. WongPrincipal Accounting Officer
- RLRichard L. LindstromIndependent Director
- GMGary M. WinerIndependent Director
- EGElizabeth G. O'FarrellIndependent Director
- Company NameTarsus Pharmaceuticals, Inc.Stock CodeTARSPositionIndependent DirectorColleagues
- BRBobak R. AzamianCo-Founder, President, CEO & Chairman
- JSJeffrey S. FarrowCFO & Chief Strategy Officer
- SNSeshadri NeervannanChief Operating Officer
- BWBryan WahlGeneral Counsel & Corporate Secretary
- DNDavid NakasoneHead of Investor Relations
- WLWendy L. YarnoLead Independent Director
- SWScott William MorrisonIndependent Director
- BCBhaskar ChaudhuriIndependent Director
